Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()

Breast cancer (BCa) molecular subtypes include luminal A, luminal B, normal-like, HER-2–enriched, and basal-like tumors, among which luminal B and basal-like cancers are highly aggressive. Biochemical pathways associated with patient survival or treatment response in these more aggressive subtypes a...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Putluri, Nagireddy, Maity, Suman, Kommangani, Ramakrishna, Creighton, Chad J., Putluri, Vasanta, Chen, Fengju, Nanda, Sarmishta, Bhowmik, Salil Kumar, Terunuma, Atsushi, Dorsey, Tiffany, Nardone, Agostina, Fu, Xiaoyong, Shaw, Chad, Sarkar, Tapasree Roy, Schiff, Rachel, Lydon, John P., O’Malley, Bert W., Ambs, Stefan, Das, Gokul M., Michailidis, George, Sreekumar, Arun
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Neoplasia Press 2014
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4198742/
https://ncbi.nlm.nih.gov/pubmed/25016594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.05.007
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια